Accustem Sciences Inc. (ACUT)
USD 0.55
(14.58%)
USD 0.55
(14.58%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -3.74 Million USD | -458.66% |
| 2021 | -670.61 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -2.5 Million USD | 99.63% |
| 2023 Q3 | -598.52 Thousand USD | -60.57% |
| 2023 Q2 | -372.75 Thousand USD | 85.09% |
| 2022 Q3 | -899.12 Thousand USD | 16.61% |
| 2022 Q2 | -1.07 Million USD | -36.39% |
| 2022 Q1 | -790.53 Thousand USD | -17.88% |
| 2022 FY | -3.74 Million USD | -458.66% |
| 2022 Q4 | -677.97 Million USD | -75304.26% |
| 2021 Q4 | -670.61 Thousand USD | 0.0% |
| 2021 FY | -670.61 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -180.54% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 46.348% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 107.072% |
| Nascent Biotech, Inc. | -2.08 Million USD | -79.454% |
| Rebus Holdings, Inc. | -1.02 Million USD | -267.296% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 105.752% |
| Qrons Inc. | -789.34 Thousand USD | -374.623% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -492.406% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 94.015% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -801.711% |
| Skye Bioscience, Inc. | -37.64 Million USD | 90.048% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 95.002% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 43.03% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -1270.297% |
| SQZ Biotechnologies Company | -79.46 Million USD | 95.285% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -29.527% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -105.787% |
| Mesoblast Limited | -87.95 Million USD | 95.741% |
| Marizyme, Inc. | -65.34 Million USD | 94.267% |
| Genus plc | 7.9 Million USD | 147.423% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 65.603% |
| Pharming Group N.V. | -10.54 Million USD | 64.482% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -72.661% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -0.975% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 57.639% |
| ContraFect Corporation | -65.15 Million USD | 94.25% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 23.324% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -116.875% |
| IMV Inc. | -36.48 Million USD | 89.732% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 53.517% |
| MultiCell Technologies, Inc. | -380.07 USD | -985618.157% |
| ONE Bio Corp. | 8.67 Million USD | 143.178% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 92.752% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -195.661% |
| Q BioMed Inc. | -2.05 Million USD | -82.566% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -0.359% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -57.355% |
| Biomind Labs Inc. | -1.21 Million USD | -208.52% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 93.727% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -20.783% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 52.596% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -92.198% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -24916.153% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 76.395% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 35.598% |
| GB Sciences, Inc. | -1.36 Million USD | -175.133% |
| Alpha Cognition Inc. | -13.77 Million USD | 72.798% |
| HST Global, Inc. | -146.21 Thousand USD | -2462.355% |
| CSL Limited | 2.64 Billion USD | 100.142% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -113.499% |
| Halberd Corporation | -79.67 Thousand USD | -4602.067% |
| Enzolytics Inc. | -2.17 Million USD | -72.104% |
| Agentix Corp. | -1.37 Million USD | -172.623% |
| Resverlogix Corp. | -3.61 Million USD | -3.779% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -18.13% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 98.73% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 3922.877% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 154.103% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 5.703% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -23.802% |
| AVAX Technologies, Inc. | -6.41 Million USD | 41.587% |
| Zenith Capital Corp. | -10.59 Million USD | 64.643% |
| Genscript Biotech Corporation | -95.47 Million USD | 96.076% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -16019.176% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 9.636% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -6098.513% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -86.843% |
| Kadimastem Ltd | -3.3 Million USD | -13.274% |
| Helix BioMedix, Inc. | -1.05 Million USD | -254.755% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 1.901% |
| BioStem Technologies, Inc. | -8.48 Million USD | 55.836% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -748.818% |
| LadRx Corporation | 400.44 Thousand USD | 1035.569% |
| Cell Source, Inc. | -5.32 Million USD | 29.595% |
| Regen BioPharma, Inc. | 1.02 Million USD | 466.037% |
| Regen BioPharma, Inc. | 1.02 Million USD | 466.037% |
| NovAccess Global Inc. | -4.76 Million USD | 21.445% |
| Affymax, Inc. | -14.42 Million USD | 74.026% |
| Itoco Inc. | -1.86 Million USD | -100.451% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 15.669% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -124.471% |
| Mobile Lads Corp. | -2.26 Million USD | -65.53% |
| CytoDyn Inc. | -49.84 Million USD | 92.483% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -4640.322% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -1542.251% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -297.908% |
| SYBLEU INC | -180.3 Thousand USD | -1977.835% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -132.302% |
| International Stem Cell Corporation | -131 Thousand USD | -2759.862% |
| Bioxytran, Inc. | -4.28 Million USD | 12.467% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -6803.042% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -48.065% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 92.207% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -77.219% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -379.765% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -18.258% |
| Neutra Corp. | -233.46 Thousand USD | -1504.703% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 81.537% |
| PureTech Health plc | -65.69 Million USD | 94.297% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 82.384% |
| IXICO plc | -1.17 Million USD | -218.032% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 62.26% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 93.442% |
| CSL Limited | 2.64 Billion USD | 100.142% |
| Cellectis S.A. | -103.17 Million USD | 96.369% |